Skip to main content
| Hans-Günter Meyer-Thompson | Hepatitiden

The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: role of the treatment regimen.

The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: role of the treatment regimen.

Innes H, Barclay ST, Hayes PC, Fraser A, Dillon JF, Stanley A, Bathgate A, McDonald SA, Goldberg D, Valerio H, Fox R, Kennedy N, Bramley P, Hutchinson SJ.

J Hepatol. 2017 Nov 15. pii: S0168-8278(17)32429-7. doi: 10.1016/j.jhep.2017.10.033.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29155019